Knowledge, attitudes and perceptions of Latin American healthcare workers relating to antibiotic stewardship and antibiotic use: a cross-sectional multi-country study.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 27 01 2024
accepted: 16 04 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 25 4 2024
Statut: epublish

Résumé

The burden of antimicrobial resistance (AMR) in Latin America is high. Little is known about healthcare workers' (HCWs) knowledge, attitudes, and perceptions of antimicrobial stewardship (AS), AMR, and antibiotic use (AU) in the region. HCWs from 42 hospitals from 5 Latin American countries were invited to take an electronic, voluntary, anonymous survey regarding knowledge, attitudes, and perceptions of AS, AMR, and AU between March-April 2023. Overall, 996 HCWs completed the survey (52% physicians, 32% nurses, 11% pharmacists, 3% microbiologists, and 2% "other"). More than 90% of respondents indicated optimizing AU was a priority at their healthcare facility (HCF), 69% stated the importance of AS was communicated at their HCF, and 23% were unfamiliar with the term "antibiotic stewardship". Most (> 95%) respondents acknowledged that appropriate AU can reduce AMR; however, few thought AU (< 30%) or AMR (< 50%) were a problem in their HCF. Lack of access to antibiogram and to locally endorsed guidelines was reported by 51% and 34% of HCWs, respectively. Among prescribers, 53% did not consider non-physicians' opinions to make antibiotic-related decisions, 22% reported not receiving education on how to select antibiotics based on culture results and 60% stated patients and families influence their antibiotic decisions. Although HCWs perceived improving AU as a priority, they did not perceive AU or AMR as a problem in their HCF. AS opportunities include improved access to guidelines, access to AMR/AU data, teamwork, and education on AS for HCWs and patients and families.

Sections du résumé

BACKGROUND BACKGROUND
The burden of antimicrobial resistance (AMR) in Latin America is high. Little is known about healthcare workers' (HCWs) knowledge, attitudes, and perceptions of antimicrobial stewardship (AS), AMR, and antibiotic use (AU) in the region.
METHODS METHODS
HCWs from 42 hospitals from 5 Latin American countries were invited to take an electronic, voluntary, anonymous survey regarding knowledge, attitudes, and perceptions of AS, AMR, and AU between March-April 2023.
FINDINGS RESULTS
Overall, 996 HCWs completed the survey (52% physicians, 32% nurses, 11% pharmacists, 3% microbiologists, and 2% "other"). More than 90% of respondents indicated optimizing AU was a priority at their healthcare facility (HCF), 69% stated the importance of AS was communicated at their HCF, and 23% were unfamiliar with the term "antibiotic stewardship". Most (> 95%) respondents acknowledged that appropriate AU can reduce AMR; however, few thought AU (< 30%) or AMR (< 50%) were a problem in their HCF. Lack of access to antibiogram and to locally endorsed guidelines was reported by 51% and 34% of HCWs, respectively. Among prescribers, 53% did not consider non-physicians' opinions to make antibiotic-related decisions, 22% reported not receiving education on how to select antibiotics based on culture results and 60% stated patients and families influence their antibiotic decisions.
CONCLUSIONS CONCLUSIONS
Although HCWs perceived improving AU as a priority, they did not perceive AU or AMR as a problem in their HCF. AS opportunities include improved access to guidelines, access to AMR/AU data, teamwork, and education on AS for HCWs and patients and families.

Identifiants

pubmed: 38664757
doi: 10.1186/s13756-024-01400-w
pii: 10.1186/s13756-024-01400-w
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

47

Subventions

Organisme : CDC HHS
ID : 75D30121C11953
Pays : United States
Organisme : CDC HHS
ID : 75D30121C11953
Pays : United States
Organisme : CDC HHS
ID : 75D30121C11953
Pays : United States
Organisme : CDC HHS
ID : 75D30121C11953
Pays : United States
Organisme : CDC HHS
ID : 75D30121C11953
Pays : United States
Organisme : CDC HHS
ID : 75D30121C11953
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–87.
doi: 10.1016/S0140-6736(15)00473-0 pubmed: 26603922
Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10:167–75.
doi: 10.1016/S1473-3099(10)70027-X pubmed: 20185095
Fabre V, Secaira C, Cosgrove SE, et al. Deep Dive Into Gaps and Barriers to Implementation of Antimicrobial Stewardship Programs in Hospitals in Latin America. Clin Infect Dis. 2023;77:S53–61.
doi: 10.1093/cid/ciad184 pubmed: 37406044 pmcid: 10321692
Jeong HJLW. The level of collapse we are allowed: comparison of different response scales in safety attitudes questionnaire. Biom Biostat Int J. 2016;4:128–34.
Wester CW, Durairaj L, Evans AT, Schwartz DN, Husain S, Martinez E. Antibiotic resistance: a survey of physician perceptions. Arch Intern Med. 2002;162:2210–6.
doi: 10.1001/archinte.162.19.2210 pubmed: 12390064
Zetts RM, Garcia AM, Doctor JN, Gerber JS, Linder JA, Hyun DY. Primary care physicians’ attitudes and perceptions towards antibiotic resistance and antibiotic stewardship: a national survey. Open Forum Infect Dis. 2020;7:244.
doi: 10.1093/ofid/ofaa244
Monsees EA, Tamma PD, Cosgrove SE, Miller MA, Fabre V. Integrating bedside nurses into antibiotic stewardship: a practical approach. Infect Control Hosp Epidemiol. 2019;40:579–84.
doi: 10.1017/ice.2018.362 pubmed: 30786944
Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62:e51–77.
doi: 10.1093/cid/ciw118 pubmed: 27080992 pmcid: 5006285
Yu K, Rho J, Morcos M, et al. Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams. Am J Health Syst Pharm. 2014;71:1019–28.
doi: 10.2146/ajhp130612 pubmed: 24865759
Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy. Am J Health Syst Pharm. 2005;62:1596–605.
doi: 10.2146/ajhp040555 pubmed: 16030370
Bartles R, Dickson A, Babade O. A systematic approach to quantifying infection prevention staffing and coverage needs. Am J Infect Control. 2018;46:487–91.
doi: 10.1016/j.ajic.2017.11.006 pubmed: 29307751
Quiros R VM. Are Cultural Determinants Related With the Use of Antibiotics and Emergence of Multidrug-Resistant Microorganisms? Open Forum Infectious Diseases. 2015;2(1):203.  https://doi.org/10.1093/ofid/ofv133.80 .
Fabre V, Cosgrove SE, Secaira C, et al. Antimicrobial stewardship in Latin America: past, present, and future. Antimicrob Steward Healthc Epidemiol. 2022;2: e68.
doi: 10.1017/ash.2022.47 pubmed: 36483374 pmcid: 9726506
Sirota M, Round T, Samaranayaka S, Kostopoulou O. Expectations for antibiotics increase their prescribing: causal evidence about localized impact. Health Psychol. 2017;36:402–9.
doi: 10.1037/hea0000456 pubmed: 28206788

Auteurs

Valeria Fabre (V)

Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halstead 824, Baltimore, MD, 21287, USA. mfabre1@jhmi.edu.

Sara E Cosgrove (SE)

Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halstead 824, Baltimore, MD, 21287, USA.

Fernanda C Lessa (FC)

International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Twisha S Patel (TS)

International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Guadalupe Reyes-Morales (G)

Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halstead 824, Baltimore, MD, 21287, USA.

Washington R Aleman (WR)

Hospital Alcivar, Guayaquil, Ecuador.

Andrea Alvarado Alvarez (AA)

Unidad de Cirugía Cardiovascular de Guatemala, Guatemala City, Guatemala.

Bowen Aquiles (B)

Hospital Sociedad de Lucha Contra El Cáncer, Guayaquil, Ecuador.

Ana B Arauz (AB)

Departamento de Medicina, Universidad de Panamá, Panama, Panama.
Hospital Santo Tomas, Panama, Panama.

Facundo Arguello (F)

Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Maria Fernanda Barberis (MF)

Hospital Nacional Profesor Alejandro Posadas, El Palomar, Argentina.

Laura Barcan (L)

Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Maria P Bernachea (MP)

Clínica Conciencia, Neuquén, Argentina.

Marisa L Bernan (ML)

Hospital Interzonal General de Agudos San Roque, La Plata, Argentina.

Carlos Buitrago (C)

Pacifica Salud, Hospital Punta Pacifica, Panamá, Panama.

Maria Del Carmen Bangher (M)

Instituto de Cardiología de Corrientes "Juana Francisca Cabral", Corrientes, Argentina.

Ximena Castañeda (X)

Clínica De La Mujer, Bogotá, Colombia.

Angel M Colque (AM)

Hospital Medico Policial Churruca Visca, Buenos Aires, Argentina.

Alfredo Canton (A)

Pacifica Salud, Hospital Punta Pacifica, Panamá, Panama.

Rosa Contreras (R)

Hospital Dr. Marcial V. Quiroga, San Juan, Argentina.

Silvia Correa (S)

Hospital Municipal de Trauma Dr. Federico Abete, Malvinas Argentinas, Argentina.

Gustavo Costilla Campero (GC)

Hospital Angel C. Padilla, Tucumán, Argentina.

Lidia Espinola (L)

Hospital El Cruce, Buenos Aires, Argentina.

Clara Esquivel (C)

Hospital San Benito, Peten, Guatemala.

Cecilia Ezcurra (C)

Hospital Alemán, Buenos Aires, Argentina.

Leandro A Falleroni (LA)

Hospital Provincial de Rosario, Rosario, Argentina.

Johana Fernandez (J)

Hospital Dr. Guillermo Rawson, San Juan, Argentina.

Sandra Ferrari (S)

Hospital Dr. Guillermo Rawson, San Juan, Argentina.

Natalia Frassone (N)

Clínica Universitaria Privada Reina Fabiola, Córdoba, Argentina.

Carlos Garcia Cruz (CG)

Hospital Sociedad de Lucha Contra El Cáncer, Guayaquil, Ecuador.

Maria Isabel Garzón (MI)

Hospital Privado Universitario de Córdoba, Córdoba, Argentina.

Carlos H Gomez Quintero (CHG)

Clínica De La Mujer, Bogotá, Colombia.
Hospital Militar Central, Bogotá, Colombia.

José A Gonzalez (JA)

Hospital Irma de Lourdes Tzanetatos, Panama, Panama.

Lucrecia Guaymas (L)

Clinica Privada Provincial, Buenos Aires, Argentina.

Fausto Guerrero-Toapanta (F)

Hospital Carlos Andrade Marín, Quito, Ecuador.

Sandra Lambert (S)

Hospital El Cruce, Buenos Aires, Argentina.

Diego Laplume (D)

Hospital Nacional Profesor Alejandro Posadas, El Palomar, Argentina.

Paola R Lazarte (PR)

Maternidad Nuestra, Tucumán, Argentina.

César G Lemir (CG)

Hospital San Bernardo, Salta, Argentina.

Angelica Lopez (A)

Hospital Alcivar, Guayaquil, Ecuador.

Itzel L Lopez (IL)

Clinica Hospital San Fernando, Panama, Panama.

Herberth Maldonado (H)

Unidad de Cirugía Cardiovascular de Guatemala, Guatemala City, Guatemala.

Guadalupe Martinez (G)

Hospital San Bernardo, Salta, Argentina.

Diego M Maurizi (DM)

Hospital Municipal de Agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina.

Mario Melgar (M)

Hospital Roosevelt, Guatemala, Guatemala.

Florencia Mesplet (F)

Hospital Cesar Milstein, Buenos Aires, Argentina.

Carlos Morales Pertuz (CM)

Hospital Del Tunal, Bogotá, Colombia.

Cristina Moreno (C)

Hospital Metropolitano, Quito, Ecuador.

Gabriela L Moya (GL)

Clínica Conciencia, Neuquén, Argentina.

Yanina Nuccetelli (Y)

Instituto de Diagnostico, La Plata, Argentina.

Glendys Núñez (G)

Hospital Santo Tomas, Panama, Panama.

Carolina Osuna (C)

Hospital Zonal General de Agudos Dr. Alberto Eurnekian, Buenos Aires, Argentina.

Belén Palacio (B)

Sanatorio Allende Nueva Córdoba, Córdoba, Argentina.

Florencia Pellice (F)

Hospital Dr. Marcial V. Quiroga, San Juan, Argentina.

Carla Raffo (C)

Hospital Municipal de Trauma Dr. Federico Abete, Malvinas Argentinas, Argentina.

Fanny Reino Choto (FR)

Hospital Carlos Andrade Marín, Quito, Ecuador.

Gerardo Ricoy (G)

Hospital Medico Policial Churruca Visca, Buenos Aires, Argentina.

Viviana Rodriguez (V)

Hospital Alemán, Buenos Aires, Argentina.

Federico Romero (F)

Sanatorio Allende Nueva Córdoba, Córdoba, Argentina.

Juan J Romero (JJ)

Hospital Vozandes, Quito, Ecuador.

Maria Eugenia Russo (ME)

Hospital Interzonal General de Agudos San Roque, La Plata, Argentina.

Graciela Sadino (G)

Clínica Universitaria Privada Reina Fabiola, Córdoba, Argentina.

Nancy Sandoval (N)

Hospital Roosevelt, Guatemala, Guatemala.

Mirta G Silva (MG)

Hospital Zonal General de Agudos Dr. Alberto Eurnekian, Buenos Aires, Argentina.

Alejandra M Urueña (AM)

Maternidad Nuestra, Tucumán, Argentina.

Ligia Vence Reyes (LV)

The Panama Clinic, Panama, Panama.

Hugo Videla (H)

Instituto de Diagnostico, La Plata, Argentina.

Marisol Valle (M)

Hospital Municipal de Agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina.

Silvia Vera Amate Perez (SVA)

Hospital Angel C. Padilla, Tucumán, Argentina.

Hernan Vergara-Samur (H)

Hospital Militar Central, Bogotá, Colombia.

Silvina Villamandos (S)

Instituto de Cardiología de Corrientes "Juana Francisca Cabral", Corrientes, Argentina.

Olmedo Villarreal (O)

Hospital Irma de Lourdes Tzanetatos, Panama, Panama.

Alejandra Viteri (A)

Hospital Cesar Milstein, Buenos Aires, Argentina.

Eduardo Warley (E)

Clinica Privada Provincial, Buenos Aires, Argentina.

Rodolfo E Quiros (RE)

Sanatorio Las Lomas, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH